Dr. Iwase on Elevated Neutrophil to Lymphocyte Ratio to Predict Survival Outcome in TNBC

Toshiaki Iwase, MD
Published: Thursday, Jan 14, 2016



Toshiaki Iwase, MD, Department of General Surgery, Chiba Graduate School of Medicine, Chiba, Japan, discusses a study that examined elevated neutrophil to lymphocyte ratio to predict survival outcomes after recurrence in patients with triple-negative breast cancer (TNBC).

Recent studies show that obesity plays a role in causing chronic inflammation and limited research focuses on effects of obesity on recurrent breast cancer treatments. In this study, researchers sought to clarify the impact of obesity-related inflammation by using the neutrophil to lymphocyte ratio in recurrent breast cancer treatment.

Results showed that there was no correlation between obesity and the neutrophil to lymphocyte ratio, Iwase explains. However, it was found that the intrinsic subtype was significantly related to inflammation, leading to pre-sarcopenia and a worse overall survival.

SELECTED
LANGUAGE


Toshiaki Iwase, MD, Department of General Surgery, Chiba Graduate School of Medicine, Chiba, Japan, discusses a study that examined elevated neutrophil to lymphocyte ratio to predict survival outcomes after recurrence in patients with triple-negative breast cancer (TNBC).

Recent studies show that obesity plays a role in causing chronic inflammation and limited research focuses on effects of obesity on recurrent breast cancer treatments. In this study, researchers sought to clarify the impact of obesity-related inflammation by using the neutrophil to lymphocyte ratio in recurrent breast cancer treatment.

Results showed that there was no correlation between obesity and the neutrophil to lymphocyte ratio, Iwase explains. However, it was found that the intrinsic subtype was significantly related to inflammation, leading to pre-sarcopenia and a worse overall survival.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?May 31, 20191.5
Community Practice Connections™: A Better Way to Stop Pain: Paths Toward Responsible Postsurgical Pain Management for Patients With Breast CancerMay 31, 20191.5
Publication Bottom Border
Border Publication
x